The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $68.21

Today's change-0.30 -0.44%
Updated July 2 4:02 PM EDT. Delayed by at least 15 minutes.
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $68.21

Today's change-0.30 -0.44%
Updated July 2 4:02 PM EDT. Delayed by at least 15 minutes.

AbbVie Inc crosses below 20-day moving average

AbbVie Inc closed lower Thursday, dropping (U.S.)$0.30 or 0.44% to (U.S.)$68.21 and crossing below its 20-day moving average. Shares have lost 2.31% over the last five days, but sit 3.60% below their 52-week high. This security has outperformed the S&P 500 by 12.21% during the last year.

Key company metrics

  • Open(U.S.) $68.68
  • Previous close(U.S.) $68.51
  • High(U.S.) $68.90
  • Low(U.S.) $67.79
  • Bid / Ask-- / --
  • YTD % change+4.23%
  • Volume6,245,709
  • Average volume (10-day)9,485,694
  • Average volume (1-month)9,409,246
  • Average volume (3-month)10,919,663
  • 52-week range(U.S.) $51.37 to (U.S.) $70.76
  • Beta--
  • Trailing P/E60.64×
  • P/E 1 year forward16.17×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.04
  • Dividend yield2.99%
  • Trailing EPS(U.S.) $1.12
Updated July 2 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+8.89%

Based on its net profit margin of 8.89%, AbbVie Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.58%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue5,0405,4525,0194,926
Total other revenue--------
Total revenue5,0405,4525,0194,926
Gross profit4,0984,3333,9553,837
Total cost of revenue9421,1191,0641,089
Total operating expense3,3535,8674,0593,411
Selling / general / administrative1,3543,3411,5951,448
Research & development811879812834
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)2462831516
Other operating expenses, total--500250--
Operating income1,687-4159601,515
Interest income (expense), net non-operating-132-139-148-73
Gain (loss) on sale of assets--------
Other--------
Income before tax1,396-1,0376871,433
Income after tax1,022-8105061,098
Income tax, total374-227181335
Net income1,022-8105061,098
Total adjustments to net income--------
Net income before extra. items1,022-8105061,098
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,022-8105061,098
Inc. avail. to common incl. extra. items1,022-8105061,098
Diluted net income1,022-8105061,098
Dilution adjustment----0--
Diluted weighted average shares1,6081,5951,6101,608
Diluted EPS excluding extraordinary itemsvalue per share0.64-0.510.310.68
Dividends per sharevalue per share0.510.420.420.42
Diluted normalized EPSvalue per share0.77-0.490.510.69